-
1
-
-
7244257375
-
The longer term outcome of children born to mothers with epilepsy
-
Adab N., Kini U., Vinten J., Ayres J., Baker G., Clayton-Smith J., Coyle H., Fryer A., Gorry J., Gregg J., Mawer G., Nicolaides P., Pickering L., Tunnicliffe L., and Chadwick D.W. The longer term outcome of children born to mothers with epilepsy. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1575-1583
-
(2004)
J. Neurol. Neurosurg. Psychiatry
, vol.75
, pp. 1575-1583
-
-
Adab, N.1
Kini, U.2
Vinten, J.3
Ayres, J.4
Baker, G.5
Clayton-Smith, J.6
Coyle, H.7
Fryer, A.8
Gorry, J.9
Gregg, J.10
Mawer, G.11
Nicolaides, P.12
Pickering, L.13
Tunnicliffe, L.14
Chadwick, D.W.15
-
2
-
-
42149106747
-
Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: involvement of Ying-Yang 1
-
Aguirre G., Rosas S., Lopez-Bayghen E., and Ortega A. Valproate-dependent transcriptional regulation of GLAST/EAAT1 expression: involvement of Ying-Yang 1. Neurochem. Int. 52 (2008) 1322-1331
-
(2008)
Neurochem. Int.
, vol.52
, pp. 1322-1331
-
-
Aguirre, G.1
Rosas, S.2
Lopez-Bayghen, E.3
Ortega, A.4
-
3
-
-
0037390202
-
Neurofilaments and neurological disease
-
Al-Chalabi A., and Miller C.C. Neurofilaments and neurological disease. Bioessays 25 (2003) 346-355
-
(2003)
Bioessays
, vol.25
, pp. 346-355
-
-
Al-Chalabi, A.1
Miller, C.C.2
-
4
-
-
0027508276
-
Parkinsonian syndrome in childhood after sodium valproate administration
-
Alvarez-Gomez M.J., Vaamonde J., Narbona J., Barao M., Barona P., Brannan T., Gudin M., and Ibanez R. Parkinsonian syndrome in childhood after sodium valproate administration. Clin. Neuropharmacol. 16 (1993) 451-455
-
(1993)
Clin. Neuropharmacol.
, vol.16
, pp. 451-455
-
-
Alvarez-Gomez, M.J.1
Vaamonde, J.2
Narbona, J.3
Barao, M.4
Barona, P.5
Brannan, T.6
Gudin, M.7
Ibanez, R.8
-
5
-
-
0029794519
-
Reversible parkinsonism and cognitive impairment with chronic valproate use
-
Armon C., Shin C., Miller P., Carwile S., Brown E., Edinger J.D., and Paul R.G. Reversible parkinsonism and cognitive impairment with chronic valproate use. Neurology 47 (1996) 626-635
-
(1996)
Neurology
, vol.47
, pp. 626-635
-
-
Armon, C.1
Shin, C.2
Miller, P.3
Carwile, S.4
Brown, E.5
Edinger, J.D.6
Paul, R.G.7
-
6
-
-
71949098755
-
Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease
-
Bahat-Stroomza M., Barhum Y., Levy Y.S., Karpov O., Bulvik S., Melamed E., and Offen D. Induction of adult human bone marrow mesenchymal stromal cells into functional astrocyte-like cells: potential for restorative treatment in Parkinson's disease. J. Mol. Neurosci. 39 (2009) 199-210
-
(2009)
J. Mol. Neurosci.
, vol.39
, pp. 199-210
-
-
Bahat-Stroomza, M.1
Barhum, Y.2
Levy, Y.S.3
Karpov, O.4
Bulvik, S.5
Melamed, E.6
Offen, D.7
-
7
-
-
0028795044
-
Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain
-
Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Vandlen R.A., Rosenthal A., and Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373 (1995) 339-341
-
(1995)
Nature
, vol.373
, pp. 339-341
-
-
Beck, K.D.1
Valverde, J.2
Alexi, T.3
Poulsen, K.4
Moffat, B.5
Vandlen, R.A.6
Rosenthal, A.7
Hefti, F.8
-
8
-
-
0026015881
-
Clinical pharmacology of valpromide
-
Bialer M. Clinical pharmacology of valpromide. Clin. Pharmacokinet 20 (1991) 114-122
-
(1991)
Clin. Pharmacokinet
, vol.20
, pp. 114-122
-
-
Bialer, M.1
-
9
-
-
0028281080
-
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group
-
Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. Jama 271 (1994) 918-924
-
(1994)
Jama
, vol.271
, pp. 918-924
-
-
Bowden, C.L.1
Brugger, A.M.2
Swann, A.C.3
Calabrese, J.R.4
Janicak, P.G.5
Petty, F.6
Dilsaver, S.C.7
Davis, J.M.8
Rush, A.J.9
Small, J.G.10
-
10
-
-
0033845743
-
Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells
-
Bown C.D., Wang J.F., and Young L.T. Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells. Neuropharmacology 39 (2000) 2162-2169
-
(2000)
Neuropharmacology
, vol.39
, pp. 2162-2169
-
-
Bown, C.D.1
Wang, J.F.2
Young, L.T.3
-
11
-
-
33845296450
-
Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes
-
Chen P.S., Peng G.S., Li G., Yang S., Wu X., Wang C.C., Wilson B., Lu R.B., Gean P.W., Chuang D.M., and Hong J.S. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes. Mol. Psychiatry 11 (2006) 1116-1125
-
(2006)
Mol. Psychiatry
, vol.11
, pp. 1116-1125
-
-
Chen, P.S.1
Peng, G.S.2
Li, G.3
Yang, S.4
Wu, X.5
Wang, C.C.6
Wilson, B.7
Lu, R.B.8
Gean, P.W.9
Chuang, D.M.10
Hong, J.S.11
-
12
-
-
3042592397
-
Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells
-
Cho T., and Tiffany-Castiglioni E. Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells. J. Toxicol. Environ. Health A 67 (2004) 987-1000
-
(2004)
J. Toxicol. Environ. Health A
, vol.67
, pp. 987-1000
-
-
Cho, T.1
Tiffany-Castiglioni, E.2
-
13
-
-
0036214297
-
Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease
-
Cunningham L.A., and Su C. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease. Exp. Neurol. 174 (2002) 230-242
-
(2002)
Exp. Neurol.
, vol.174
, pp. 230-242
-
-
Cunningham, L.A.1
Su, C.2
-
14
-
-
0028015728
-
Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease
-
Cunningham L.A., Short M.P., Breakefield X.O., and Bohn M.C. Nerve growth factor released by transgenic astrocytes enhances the function of adrenal chromaffin cell grafts in a rat model of Parkinson's disease. Brain Res. 658 (1994) 219-231
-
(1994)
Brain Res.
, vol.658
, pp. 219-231
-
-
Cunningham, L.A.1
Short, M.P.2
Breakefield, X.O.3
Bohn, M.C.4
-
15
-
-
13644254946
-
Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons
-
Di Daniel E., Mudge A.W., and Maycox P.R. Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons. Bipolar Disord. 7 (2005) 33-41
-
(2005)
Bipolar Disord.
, vol.7
, pp. 33-41
-
-
Di Daniel, E.1
Mudge, A.W.2
Maycox, P.R.3
-
16
-
-
0141988725
-
Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis
-
Dou H., Birusingh K., Faraci J., Gorantla S., Poluektova L.Y., Maggirwar S.B., Dewhurst S., Gelbard H.A., and Gendelman H.E. Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J. Neurosci. 23 (2003) 9162-9170
-
(2003)
J. Neurosci.
, vol.23
, pp. 9162-9170
-
-
Dou, H.1
Birusingh, K.2
Faraci, J.3
Gorantla, S.4
Poluektova, L.Y.5
Maggirwar, S.B.6
Dewhurst, S.7
Gelbard, H.A.8
Gendelman, H.E.9
-
17
-
-
1942505883
-
Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate
-
Easterford K., Clough P., Kellett M., Fallon K., and Duncan S. Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology 62 (2004) 1435-1437
-
(2004)
Neurology
, vol.62
, pp. 1435-1437
-
-
Easterford, K.1
Clough, P.2
Kellett, M.3
Fallon, K.4
Duncan, S.5
-
18
-
-
0032846284
-
Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y
-
Encinas M., Iglesias M., Llecha N., and Comella J.X. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y. J. Neurochem. 73 (1999) 1409-1421
-
(1999)
J. Neurochem.
, vol.73
, pp. 1409-1421
-
-
Encinas, M.1
Iglesias, M.2
Llecha, N.3
Comella, J.X.4
-
19
-
-
9144257236
-
Normal intelligence in children with prenatal exposure to carbamazepine
-
Gaily E., Kantola-Sorsa E., Hiilesmaa V., Isoaho M., Matila R., Kotila M., Nylund T., Bardy A., Kaaja E., and Granstrom M.L. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology 62 (2004) 28-32
-
(2004)
Neurology
, vol.62
, pp. 28-32
-
-
Gaily, E.1
Kantola-Sorsa, E.2
Hiilesmaa, V.3
Isoaho, M.4
Matila, R.5
Kotila, M.6
Nylund, T.7
Bardy, A.8
Kaaja, E.9
Granstrom, M.L.10
-
20
-
-
0020517951
-
Lewy bodies of Parkinson's disease contain neurofilament antigens
-
Goldman J.E., Yen S.H., Chiu F.C., and Peress N.S. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 221 (1983) 1082-1084
-
(1983)
Science
, vol.221
, pp. 1082-1084
-
-
Goldman, J.E.1
Yen, S.H.2
Chiu, F.C.3
Peress, N.S.4
-
21
-
-
0037052633
-
MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells
-
Gomez-Santos C., Ferrer I., Reiriz J., Vinals F., Barrachina M., and Ambrosio S. MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 935 (2002) 32-39
-
(2002)
Brain Res.
, vol.935
, pp. 32-39
-
-
Gomez-Santos, C.1
Ferrer, I.2
Reiriz, J.3
Vinals, F.4
Barrachina, M.5
Ambrosio, S.6
-
22
-
-
0031931040
-
Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment
-
Guerrini R., Belmonte A., Canapicchi R., Casalini C., and Perucca E. Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment. Epilepsia 39 (1998) 27-32
-
(1998)
Epilepsia
, vol.39
, pp. 27-32
-
-
Guerrini, R.1
Belmonte, A.2
Canapicchi, R.3
Casalini, C.4
Perucca, E.5
-
23
-
-
3242788185
-
Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis
-
Hao Y., Creson T., Zhang L., Li P., Du F., Yuan P., Gould T.D., Manji H.K., and Chen G. Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J. Neurosci. 24 (2004) 6590-6599
-
(2004)
J. Neurosci.
, vol.24
, pp. 6590-6599
-
-
Hao, Y.1
Creson, T.2
Zhang, L.3
Li, P.4
Du, F.5
Yuan, P.6
Gould, T.D.7
Manji, H.K.8
Chen, G.9
-
24
-
-
0141918851
-
Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase
-
Hasegawa T., Matsuzaki M., Takeda A., Kikuchi A., Furukawa K., Shibahara S., and Itoyama Y. Increased dopamine and its metabolites in SH-SY5Y neuroblastoma cells that express tyrosinase. J. Neurochem. 87 (2003) 470-475
-
(2003)
J. Neurochem.
, vol.87
, pp. 470-475
-
-
Hasegawa, T.1
Matsuzaki, M.2
Takeda, A.3
Kikuchi, A.4
Furukawa, K.5
Shibahara, S.6
Itoyama, Y.7
-
25
-
-
0037437833
-
Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds
-
Hong M.S., Hong S.J., Barhoumi R., Burghardt R.C., Donnelly K.C., Wild J.R., Venkatraj V., and Tiffany-Castiglioni E. Neurotoxicity induced in differentiated SK-N-SH-SY5Y human neuroblastoma cells by organophosphorus compounds. Toxicol. Appl. Pharmacol. 186 (2003) 110-118
-
(2003)
Toxicol. Appl. Pharmacol.
, vol.186
, pp. 110-118
-
-
Hong, M.S.1
Hong, S.J.2
Barhoumi, R.3
Burghardt, R.C.4
Donnelly, K.C.5
Wild, J.R.6
Venkatraj, V.7
Tiffany-Castiglioni, E.8
-
26
-
-
0035871386
-
Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration
-
Kirik D., Winkler C., and Bjorklund A. Growth and functional efficacy of intrastriatal nigral transplants depend on the extent of nigrostriatal degeneration. J. Neurosci. 21 (2001) 2889-2896
-
(2001)
J. Neurosci.
, vol.21
, pp. 2889-2896
-
-
Kirik, D.1
Winkler, C.2
Bjorklund, A.3
-
27
-
-
4744346077
-
The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells
-
Laeng P., Pi`tts R.L., Lemire A.L., Drabik C.E., Weiner A., Tang H., Thyagarajan R., Mallon B.S., and Altar C.A. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J. Neurochem. 91 (2004) 238-251
-
(2004)
J. Neurochem.
, vol.91
, pp. 238-251
-
-
Laeng, P.1
Pitts, R.L.2
Lemire, A.L.3
Drabik, C.E.4
Weiner, A.5
Tang, H.6
Thyagarajan, R.7
Mallon, B.S.8
Altar, C.A.9
-
28
-
-
33646863671
-
Cytoprotection by lithium and valproate varies between cell types and cellular stresses
-
Lai J.S., Zhao C., Warsh J.J., and Li P.P. Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur. J. Pharmacol. 539 (2006) 18-26
-
(2006)
Eur. J. Pharmacol.
, vol.539
, pp. 18-26
-
-
Lai, J.S.1
Zhao, C.2
Warsh, J.J.3
Li, P.P.4
-
29
-
-
0037192440
-
A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration
-
Lavedan C., Buchholtz S., Nussbaum R.L., Albin R.L., and Polymeropoulos M.H. A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neurosci. Lett. 322 (2002) 57-61
-
(2002)
Neurosci. Lett.
, vol.322
, pp. 57-61
-
-
Lavedan, C.1
Buchholtz, S.2
Nussbaum, R.L.3
Albin, R.L.4
Polymeropoulos, M.H.5
-
31
-
-
0023154089
-
Nerve growth factor enhances the synthesis, phosphorylation, and metabolic stability of neurofilament proteins in PC12 cells
-
Lindenbaum M.H., Carbonetto S., and Mushynski W.E. Nerve growth factor enhances the synthesis, phosphorylation, and metabolic stability of neurofilament proteins in PC12 cells. J. Biol. Chem. 262 (1987) 605-610
-
(1987)
J. Biol. Chem.
, vol.262
, pp. 605-610
-
-
Lindenbaum, M.H.1
Carbonetto, S.2
Mushynski, W.E.3
-
32
-
-
0023933338
-
Transcriptional and post-transcriptional effects of nerve growth factor on expression of the three neurofilament subunits in PC-12 cells
-
Lindenbaum M.H., Carbonetto S., Grosveld F., Flavell D., and Mushynski W.E. Transcriptional and post-transcriptional effects of nerve growth factor on expression of the three neurofilament subunits in PC-12 cells. J. Biol. Chem. 263 (1988) 5662-5667
-
(1988)
J. Biol. Chem.
, vol.263
, pp. 5662-5667
-
-
Lindenbaum, M.H.1
Carbonetto, S.2
Grosveld, F.3
Flavell, D.4
Mushynski, W.E.5
-
33
-
-
32544432755
-
Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases
-
Masmoudi K., Gras-Champel V., Masson H., and Andrejak M. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases. Pharmacopsychiatry 39 (2006) 9-12
-
(2006)
Pharmacopsychiatry
, vol.39
, pp. 9-12
-
-
Masmoudi, K.1
Gras-Champel, V.2
Masson, H.3
Andrejak, M.4
-
34
-
-
0031729916
-
Reversible parkinsonism induced by prolonged treatment with valproate
-
Onofrj M., Thomas A., and Paci C. Reversible parkinsonism induced by prolonged treatment with valproate. J. Neurol. 245 (1998) 794-796
-
(1998)
J. Neurol.
, vol.245
, pp. 794-796
-
-
Onofrj, M.1
Thomas, A.2
Paci, C.3
-
35
-
-
0029157036
-
Reversible dementia and apparent brain atrophy during valproate therapy
-
Papazian O., Canizales E., Alfonso I., Archila R., Duchowny M., and Aicardi J. Reversible dementia and apparent brain atrophy during valproate therapy. Ann. Neurol. 38 (1995) 687-691
-
(1995)
Ann. Neurol.
, vol.38
, pp. 687-691
-
-
Papazian, O.1
Canizales, E.2
Alfonso, I.3
Archila, R.4
Duchowny, M.5
Aicardi, J.6
-
37
-
-
0030872355
-
A Menkes P-type ATPase involved in copper homeostasis in the central nervous system of the rat
-
Qian Y.C., Tiffany-Castiglioni E., and Harris E.D. A Menkes P-type ATPase involved in copper homeostasis in the central nervous system of the rat. Brain Res. Mol. Brain Res. 48 (1997) 60-66
-
(1997)
Brain Res. Mol. Brain Res.
, vol.48
, pp. 60-66
-
-
Qian, Y.C.1
Tiffany-Castiglioni, E.2
Harris, E.D.3
-
38
-
-
0034653916
-
Lead targets GRP78, a molecular chaperone, in C6 rat glioma cells
-
Qian Y.C., Harris E.D., Zheng Y., and Tiffany-Castiglioni E. Lead targets GRP78, a molecular chaperone, in C6 rat glioma cells. Toxicol. Appl. Pharmacol. 163 (2000) 260-266
-
(2000)
Toxicol. Appl. Pharmacol.
, vol.163
, pp. 260-266
-
-
Qian, Y.C.1
Harris, E.D.2
Zheng, Y.3
Tiffany-Castiglioni, E.4
-
39
-
-
17044407040
-
Differential profiles of copper-induced ROS generation in human neuroblastoma and astrocytoma cells
-
Qian Y.C., Zheng Y., Abraham L., Ramos K.S., and Tiffany-Castiglioni E. Differential profiles of copper-induced ROS generation in human neuroblastoma and astrocytoma cells. Brain Res. Mol. Brain Res. 134 (2005) 323-332
-
(2005)
Brain Res. Mol. Brain Res.
, vol.134
, pp. 323-332
-
-
Qian, Y.C.1
Zheng, Y.2
Abraham, L.3
Ramos, K.S.4
Tiffany-Castiglioni, E.5
-
40
-
-
33845638793
-
The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy
-
Ristic A.J., Vojvodic N., Jankovic S., Sindelic A., and Sokic D. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. Epilepsia 47 (2006) 2183-2185
-
(2006)
Epilepsia
, vol.47
, pp. 2183-2185
-
-
Ristic, A.J.1
Vojvodic, N.2
Jankovic, S.3
Sindelic, A.4
Sokic, D.5
-
41
-
-
0028302839
-
Reversible valproate-induced extrapyramidal disorders
-
Sasso E., Delsoldato S., Negrotti A., and Mancia D. Reversible valproate-induced extrapyramidal disorders. Epilepsia 35 (1994) 391-393
-
(1994)
Epilepsia
, vol.35
, pp. 391-393
-
-
Sasso, E.1
Delsoldato, S.2
Negrotti, A.3
Mancia, D.4
-
42
-
-
0033836436
-
Facilitatory roles of novel compounds designed from cyclopentenone prostaglandins on neurite outgrowth-promoting activities of nerve growth factor
-
Satoh T., Furuta K., Tomokiyo K., Nakatsuka D., Tanikawa M., Nakanishi M., Miura M., Tanaka S., Koike T., Hatanaka H., Ikuta K., Suzuki M., and Watanabe Y. Facilitatory roles of novel compounds designed from cyclopentenone prostaglandins on neurite outgrowth-promoting activities of nerve growth factor. J. Neurochem. 75 (2000) 1092-1102
-
(2000)
J. Neurochem.
, vol.75
, pp. 1092-1102
-
-
Satoh, T.1
Furuta, K.2
Tomokiyo, K.3
Nakatsuka, D.4
Tanikawa, M.5
Nakanishi, M.6
Miura, M.7
Tanaka, S.8
Koike, T.9
Hatanaka, H.10
Ikuta, K.11
Suzuki, M.12
Watanabe, Y.13
-
43
-
-
49849084233
-
Valproate-induced parkinsonism, glial cells and Alexander's disease
-
Sechi G.P., Conti M., Sau G.F., and Cocco G.A. Valproate-induced parkinsonism, glial cells and Alexander's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 1351-1352
-
(2008)
Prog. Neuropsychopharmacol. Biol. Psychiatry
, vol.32
, pp. 1351-1352
-
-
Sechi, G.P.1
Conti, M.2
Sau, G.F.3
Cocco, G.A.4
-
44
-
-
0037118050
-
A common mechanism of action for three mood-stabilizing drugs
-
Williams R.S., Cheng L., Mudge A.W., and Harwood A.J. A common mechanism of action for three mood-stabilizing drugs. Nature 417 (2002) 292-295
-
(2002)
Nature
, vol.417
, pp. 292-295
-
-
Williams, R.S.1
Cheng, L.2
Mudge, A.W.3
Harwood, A.J.4
-
45
-
-
0022885308
-
Reversible valproic acid-induced dementia: a case report
-
Zaret B.S., and Cohen R.A. Reversible valproic acid-induced dementia: a case report. Epilepsia 27 (1986) 234-240
-
(1986)
Epilepsia
, vol.27
, pp. 234-240
-
-
Zaret, B.S.1
Cohen, R.A.2
|